USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
This week’s Reviewer in the Spotlight, Dr. Ritesh Bhole, discusses communication in science and the value of genuine product reviews, both positive and negative
Through automation of manual tasks, Roche’s new solution is designed to simplify workflows and improve the productivity of lab personnel whilst also supporting the delivery of better patient care
The monthly safety report will be made public on the European Medicines Agency website
UP.SIGHT™ is certified to help laboratories worldwide overcome major cell line development hurdles and improve efficiency across workflows
Abbott will rapidly develop tests that can be used to help identify, isolate, and contain outbreaks when potential new virus threats are identified
The findings come from the largest study to date to look at inflammatory markers in COVID-19
New line of bioreactors is designed to ensure seamless scalability from early process development to commercial manufacturing
Panel designed to provide surveillance of ongoing mutations of virus that causes COVID-19
Once considered a vestigial organelle, primary cilia are now believed to have an important function in the central nervous system
With this partnership, Repositive is expanding its personalized medicine capabilities to support more biopharma customers
The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab
The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring
Collaboration agreement to market AZOVA COVID-19 test collection kit online
SARS-CoV-2 testing is a powerful tool for curbing the COVID-19 pandemic and safely reopening schools and businesses
Opaganib demonstrated dual anti-inflammatory and antiviral activity and targets a human cell component involved in viral replication
The license from ERS expands ZeClinics CRISPR IP portfolio and increases the validity and potency of zebrafish models for the drug discovery process
Funding of $231.8 million U.S. awarded to Ellume COVID-19 Home Test that integrates AnteoBind™ for superior sensitivity
The research brings a deeper understanding about how fructose could be linked to diabetes and obesity
International experts are joining forces to combat vaccine hesitancy by tackling its root cause
The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA